“…Since some of them are involved in host-pathogen recognition, they are also promising targets for glycomimetic compounds that could present anti-infectious properties. Designing multivalent molecules that fit the specific binding sites arrangement of β-propellers in pathogenic micro-organisms has been key to obtain high-affinity inhibitors (Goyard et al, 2018;(Jancarikova et al, 2018;(Machida et al, 2017). Because of their ability to bind strongly to glycoconjugates on cell surfaces, PropLecs are also useful biomarkers, for probing the glycosylation of proteins (Liu et al, 2018;(Machon et al, 2017), for labelling cancer cells (Audfray et al, 2015), or as tools to study the dynamics of glycolipids in membranes (Arnaud et al, 2013).…”